🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A recent study showed that 6 cycles of obinutuzumab when given after at lea...
Status
Active Not Recruiting
Location
DK-Aalborg-AALBORGUH
Start Date
2020-12-29
Trial ID
NCT04639362
Treatments Being Tested
Safety, pharmacokinetics, and preliminary efficacy of CC-122 alone and in c...
Status
Completed
Location
University of California San Diego
Start Date
2015-07-27
Trial ID
NCT02406742
Treatments Being Tested
This phase II trial studies how well ibrutinib and rituximab given together...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03710772
Venetoclax and ibrutinib have complementary activity in clearing the diseas...
Status
Terminated
Location
Kantonsspital Aarau
Start Date
2019-03-11
Trial ID
NCT03708003
Treatments Being Tested
The aim of this study is to evaluate if standard chemoimmunotherapy (FCR, B...
Status
Completed
Location
Medizinische Universitaet Wien
Start Date
2016-12-13
Trial ID
NCT02950051
Treatments Being Tested
Background: Aggressive B-cell lymphomas can be cured but people with disea...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-07-09
Trial ID
NCT04739813
Treatments Being Tested
The aim of the current trial is to evaluate if combination treatment with v...
Status
Unknown
Location
BE-Antwerpen-ZNASTUIVENBERG
Start Date
2017-06-23
Trial ID
NCT03226301
Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western c...
Status
Completed
Location
Duplicate_NHO Nagoya Medical Center /ID# 233523
Start Date
2021-11-08
Trial ID
NCT05105841
Treatments Being Tested
This phase II trial studies the effects of venetoclax and rituximab in comp...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2022-01-05
Trial ID
NCT04840602
This phase III trial compares adding a new anti-cancer drug (venetoclax) to...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-31
Trial ID
NCT03737981
Treatments Being Tested